Answers are grounded in this paper and cite their sources.
Proximal tubule (PT) injury drives renal fibrogenesis, necessitating targeted therapeutic strategies. Here, we explored whether conditioned medium (CM) from human adipose-derived mesenchymal stem cells (MSCs) overexpressing miR-29a-3p could attenuate transforming growth factor-beta 1 (TGF-β1)-induced injury in human renal proximal tubular epithelial cells (RPTECs). MSCs were transfected with a miR-29a-3p mimic or control, and the resulting CM was applied to RPTECs during sustained TGF-β1 exposure. Cellular responses were evaluated using bulk RNA-sequencing, mitochondrial membrane potential assays, and immunofluorescence. Furthermore, a 12-gene, three-axis score was constructed to quantify injury and recovery. miR-29a-3p MSC-CM effectively reduced profibrotic activation and induced a broad reversal of approximately half of the TGF-β1-induced transcriptional shifts. Notably, this CM reactivated suppressed metabolic pathways, such as oxidative phosphorylation, attenuated epithelial–mesenchymal transition and cadherin remodeling, and restored mitochondrial membrane potential. Additionally, the 12-gene, three-axis score quantified a 47.6% recovery in vitro and successfully captured progressive adaptive and failed-repair PT injury states in human kidney single-cell/nucleus datasets, including an independent validation cohort. In conclusion, miR-29a-3p MSC-CM drives a selective but robust transcriptional and functional recovery in injured RPTECs. The novel 12-gene, three-axis score provides a quantifiable, cross-dataset metric for evaluating PT injury states.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: